Abstract:A new mechanism of cancer initiation that involves the transformation of hepatocytes into preneoplastic single hepatocytes and minifoci positive for GST‐P was identified in the rat liver on the key finding of "rapid excretion of GST‐P into bile" obtained from 3D immunochemistry using a vibratome for the first time. GST‐P represents glutathione S‐transferase P‐form, a specific marker enzyme of preneoplastic foci and nodules inducible in rat livers. Background Cancer initiation has long been "unknowable" in biology and medicine. In 1987, however, Moore and our research group observed single hepatocytes and minifoci that were strongly positive for glutathione S‐transferase P‐form (GST‐P) in the rat liver as early as 2 to 3 days after initiation by diethylnitrosamine prior to the induction of GST‐P+ foci and nodules. The induction of GST‐P+ single hepatocytes, precursors of GST‐P+ foci and nodules, was considered genetic. But, the details of the induction mechanism have remained unclear despite various examinations over a long period. Methods Male Sprague‐Dawley rats (aged 6 weeks) were fed a basal diet containing either benzyl isothiocyanate (BITC, 0.5% by wt) or 2‐acetylaminofluorene (AAF, 0.04%) ad libitum for appropriate time intervals. All animals were anesthetized and euthanized. The livers obtained were excised, cut into 3‐ to 4‐mm‐thick slices and fixed in cold acetone at 4 °C. The liver specimens were then sliced into 25‐μm‐thick sections in PBS using an automated microtome (Vibratome 1500 Sectioning System, Vibratome Products, NY, USA). Immunocytochemical staining was performed in free solution, and the results were examined via digital light microscopy (Coolscope, Nikon, Tokyo). Results 3D analysis using a vibratome showed that GST‐P is rapidly excreted into the bile of the liver of animals in response to strong carcinogenic stress caused by promoters or initiators. "Rapid biliary excretion of GST‐P" was widely and commonly observed in all hepatocytes, GST‐P+ single hepatocytes, minifoci, foci and nodules under appropriate conditions. Surprisingly, on the basis of these key findings, a new mechanism of cancer initiation involving the transformation of hepatocytes into GST‐P+ single hepatocytes and minifoci in animal livers was identified. In addition, the initiation process was determined to be nongenetic because mutation is an invisible rare event. Conclusions This short review describes several details about breakthrough findings on cancer initiation in rat livers, the application of 3D analysis to other cancers and the importance in the genetic analysis in malignant diseases.

Serum Lipid Concentration in Blood from Afferent and Efferent Pulmonary Vessels in Man

Comparative tumor initiating activities of N-nitrosomethylbenzylamine and N-nitrosodimethylamine in rat liver

O6-methylguanine DNA Methyltransferase is Upregulated in Malignant Transformation of Gastric Epithelial Cells Via Its Gene Promoter DNA Hypomethylation

Proteomic Analysis of Different Temporal Expression Patterns Induced by N-Methyl-N′-nitro-N-nitrosoguanidine Treatment

Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

A new mechanism of cancer initiation that involves the transformation of hepatocytes into preneoplastic single hepatocytes and minifoci positive for glutathione S‐transferase P‐form (GST‐P) in rat livers: 3D analysis using a vibratome

[Activation of Proto-Oncogenes Induced by MNNG on Primary Culture of Human Gastric Epithelium and Immortalized Human Gastric Epithelial Cell Line].

Magellan: Charting Large-Scale Peer-to-Peer Live Streaming Topologies

[High-mobility group protein 1 promotes diethylnitrosamine-induced liver cancer formation in mice by activating mitochondrial biogenesis]

DNA Damage Triggers Imbalance of Proliferation and Apoptosis During Development of Preneoplastic Foci in the Liver of Long-Evans Cinnamon Rats.

Transplacental initiation of liver, lung, neurogenic, and connective tissue tumors by N-nitroso compounds in mice

Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.

Modifications in the carcinogen-metabolizing capacity of mouse liver treated with N-nitroso compounds.

Supporting Workflow Management Systems with traceability

Matrix metalloproteinase-9, -10, and -12, MDM2 and p53 expression in mouse liver during dimethylnitrosamine-induced oxidative stress and genomic injury

Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3, 6 or 20 weeks) and of species (rats, mice or hamsters)

Comparative carcinogenesis by some aliphatic nitrosamines in Fischer rats

Carcinogenic nitrosamines: Free radical aspects of their action

Mechanisms of Nitrosamine Bioactivation and Carcinogenesis

Metabolism-dependent mutagenicity of two structurally similar tobacco-specific nitrosamines ( N -nitrosonornicotine and N -nitrosoanabasine) in human cells, partially different CYPs being activating enzymes

Chromosome aberrations cause tumorigenesis through chromosomal rearrangements in a hepatocarcinogenesis rat model